Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients
<p>Abstract</p> <p>Background</p> <p>Taurolidin/Citrate (TauroLock™), a lock solution with broad spectrum antimicrobial activity, may prevent bloodstream infection (BSI) due to coagulase-negative staphylococci (CoNS or 'MRSE' in case of methicillin-resistant i...
Main Authors: | Fleischhack Gudrun, Bode Udo, Wiszniewsky Gertrud, Ammann Roland A, Simon Arne, Besuden Mette M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-07-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/8/102 |
Similar Items
-
HEMODIALYSIS TUNNELED CATHETERS LOCK WITH TAUROLOCK™ VERSUS A COMBINATION OF GENTAMYCINE AND HEPARINE
by: Biser K. Borisov, et al.
Published: (2023-07-01) -
Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections
by: Emine Ince, et al.
Published: (2014-01-01) -
The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients
by: Sonja van Roeden, et al.
Published: (2021-09-01) -
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
by: Marta Alvarez Nadal, et al.
Published: (2020-09-01) -
Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D
by: Néstor Fontseré, et al.
Published: (2022-09-01)